Advance Gene Therapy Pipeline for Musculoskeletal Diseases
GeneQuine Biotherapeutics Secures more than €9 Million
28-Jan-2021 -
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has raised €5.4 million in Series A financing and €3.65 million non-dilutive funding bringing the total amount raised to €9.05 million. The Series A ...
gene therapeutics
gene therapy
musculoskeletal diseases
+2